Skip to content

H2020HORIZONFP7

Stroke Alliance for Europe

Country
BEBelgium
Defence projects
0
Projects, all programmes
16
As coordinator
0
EU contribution (CORDIS)
EUR 1,123,938
Active
2008 to 2024

Projects

16 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EAST-STROKEEarly treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKEHORIZON2024ParticipantEUR 95,054
POC4TRIAGEPoint-of-Care Devices for Urgent Care TriageHORIZON2024ParticipantEUR 88,500
UMBRELLAUnleashing a CoMprehensive, Holistic and Patient Centric Stroke Management for a Better, Rapid, AdvancEd and PersonaLised Stroke Diagnosis, TreAtment and Outcome PredictionHORIZON2024ParticipantEUR 76,000
TRUSTrokeTRUSTWORTHY AI FOR IMPROVEMENT OF STROKE OUTCOMESHORIZON2023ParticipantEUR 54,250
VALIDATEV A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke TreatmentHORIZON2022ParticipantEUR 154,250
RES-Q PLUSComprehensive solutions of healthcare improvement based on the global Registry of Stroke Care QualityHORIZON2022ParticipantEUR 53,250
ANGIEMAgnetically steerable wireless Nanodevices for the tarGeted delivery of therapeutIc agents in any vascular rEgion of the bodyH20202021ParticipantEUR 102,875
ENTRAINENdoThelial macRophage Alliance In NeuroinflammationH20202019PartnerEUR 0
TENSIONEfficacy and safety of thrombectomy in stroke with extended lesion and extended time window: a randomized, controlled trialH20202018ParticipantEUR 78,375
PROOFPenumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept TrialH20202017ParticipantEUR 66,625
PRESTIGE-AFPREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial FibrillationH20202017ParticipantEUR 45,000
SVDs-at-targetSmall vessel diseases in a mechanistic perspective: Targets for Intervention Affected pathways and mechanistic exploitation for prevention of stroke and dementiaH20202016ParticipantEUR 45,025
PRECIOUSPREvention of Complications to Improve OUtcome in elderly patients with acute StrokeH20202015ParticipantEUR 45,025
EUROHYP-1European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic strokeFP72012ParticipantEUR 49,086
WAKE-UPEfficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trialFP72011ParticipantEUR 84,822
EUSTROKEEuropean Stroke Research NetworkFP72008ParticipantEUR 85,800

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.